Literature DB >> 20117799

Thoracoscopic pulmonary vein isolation in patients with atrial fibrillation and failed percutaneous ablation.

Manuel Castellá1, Daniel Pereda, Carlos A Mestres, Félix Gómez, Eduard Quintana, Jaume Mulet.   

Abstract

OBJECTIVE: Pulmonary vein isolation is indicated in patients with symptomatic isolated atrial fibrillation not controlled with antiarrhythmic therapy. We describe our surgical experience with thoracoscopic pulmonary vein isolation in patients in whom percutaneous ablation has failed.
METHODS: Thirty-four adult patients with unsuccessful catheter ablations (range 1-4, mean 2 +/- 1) underwent thoracoscopic bipolar-radiofrequency pulmonary vein isolation. Seventeen patients had paroxysmal atrial fibrillation, 12 with persistent and 5 with long-standing persistent fibrillation, for a mean of 6 years (range 3-10 years), 13 years (5-25 years), and 9 years (3-15 years), respectively.
RESULTS: There was no mortality during the procedure or follow-up (mean 16 +/- 11 months). Two patients needed conversion to thoracotomy owing to hemorrhage, and ablation could not be completed. Antiarrhythmic therapy was withdrawn 3 months postoperatively. Postoperative sinus rhythm was maintained in 82% of those with paroxysmal atrial fibrillation (13/15 at 6 months, 9/11 at 12 months), 60% had persistent atrial fibrillation (8/12 at 6 months and 6/10 at 12 months), and 20% had long-standing persistent atrial fibrillation (1/5 at 6 and 12 months). Preoperative left atrial diameter significantly differed between patients with paroxysmal fibrillation (mean 42 +/- 6 mm) and those with persistent and long-standing persistent fibrillation (means 50 +/- 4 and 47 +/- 2 mm). Left atrial size greater than 45 mm and atrial fibrillation type were preoperative factors that significantly influenced outcome in the univariate logistic regression analysis.
CONCLUSIONS: Thoracoscopic pulmonary vein isolation in patients with previously unsuccessful catheter ablations demonstrates satisfactory sinus rhythm maintenance rates in paroxysmal and persistent atrial fibrillation, but not in long-standing persistent atrial fibrillation. As with other minimally invasive surgical techniques, there is an important learning curve. 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20117799     DOI: 10.1016/j.jtcvs.2009.11.009

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Epicardial thoracoscopic ablation versus endocardial catheter ablation for management of atrial fibrillation: a systematic review and meta-analysis.

Authors:  Hyun Jung Kim; Jin Suk Kim; Tae Sik Kim
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-23

2.  Stroke prevention following modified endoscopic ablation and appendectomy for atrial fibrillation.

Authors:  Nan Ma; Zhaolei Jiang; Fei Chen; Hang Yin; Fangbao Ding; Ju Mei
Journal:  Heart Vessels       Date:  2015-09-21       Impact factor: 2.037

3.  Predictive risk factors for recurrent atrial fibrillation after modified endoscopic ablation: A 2-year follow-up.

Authors:  Kang An; Jiaquan Zhu; Nan Ma; Min Tang; Ju Mei
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

4.  Current state of the surgical treatment of atrial fibrillation.

Authors:  Elena Sandoval; Manuel Castella; Jose-Luis Pomar
Journal:  Cardiol Res Pract       Date:  2011-03-15       Impact factor: 1.866

5.  Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation.

Authors:  Chunyu Yu; Haojie Li; Heng Zhang; Zhe Zheng
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.